Significance of TIRADS classification in detection of thyroid gland cancer

Amela Begić, Miran Hadžiahmetović, Selma Agić-Bilalagić, Šejla Cerić, Sadžida Begović-Hadžimuratović, Ajla Arnautović-Halimić, Amila Bašić


Objective: Aim of this study was to retrospectively validate the effectiveness of TIRADS classification in diagnosis of thyroid cancer compared to cytological and pathohistological findings.

Methods: This observational, retrospective study included adult patients of both genders who were diagnosed with thyroid cancer and underwent thyroidectomy. The study was conducted at the Clinic for Nuclear medicine and Endocrinology of the Clinical Center University of Sarajevo in the period from June 2018 to November 2018. All patients had ultrasound (US) and TIRADS classification, fine needle aspiration (FNA) biopsy of the suspected nodules, thyroidectomy and pathohistological (PHD) analysis. TIRADS classification was compared to the results of FNA and PHD findings.

Results: A total of 100 nodules (from 76 patients) were included in the study. TIRADS classification showed that there was 1 (1.0%) nodule in TR2 class, 20 (20.0%) nodules in TR3 class, 72 (72.0%) nodules in TR4 class and 7 (7.0%) nodules in TR5 class. Comparing the results of FNA with TIRADS classification showed that there were no malignant nodules in TR2 class, in TR3 class there were 14 (70.0%) malignant nodules, in TR4 class there were 60 (83.3%) malignant nodules and in TR5 all nodules were malignant (7, 100.0%). Comparing the results of PHD with TIRADS classification showed that there were no malignant nodules in TR2 class, in TR3 class there were 17 (85.5%) malignant nodules, in TR4 class there were 71 (98.6%) malignant nodules and in TR5 class there were 7 (100.0%) malignant nodules.

Conclusion: TIRADS classification showed valid efficacy in identifying malignant thyroid nodules, although fine needle aspiration remains the most effective method. With continious improvement of TIRADS classification system we can expect decrease in unnecessary thyroid biopsies and an overall improvement of thyroid cancer diagnostics.

Keywords: Thyroid Nodule, Ultrasound Imaging, Thyroid Cancer, TIRADS, Risk Classification

Full Text:



Horvath E, Silva CF, Majlis S, Rodriguez I, Skoknic V, Castro A, et al. Prospective validation of the ultrasound based TIRADS (Thyroid Imaging Reporting And Data System) classification: results in surgically resected thyroid nodules. Eur Radiol. 2017 Jun;27(6):2619–28.

Trimboli P, Ngu R, Royer B, Giovanella L, Bigorgne C, Simo R, et al. A multicentre validation study for the EU‐TIRADS using histological diagnosis as a gold standard. Clin Endocrinol (Oxf). 2018 May 3;cen.13997.

Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006 Jun;154(6):787–803.

Vargas-Uricoechea H, Meza-Cabrera I, Herrera-Chaparro J. Concordance between the TIRADS ultrasound criteria and the BETHESDA cytology criteria on the nontoxic thyroid nodule. Thyroid Res. 2017 Dec;10(1):1.

Ahmadieh H, Azar ST. Controversies in the Management and Followup of Differentiated Thyroid Cancer: Beyond the Guidelines. J Thyroid Res. 2012;2012:1–8.

Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017 May;14(5):587–95.

Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. :8.

Shen Y, Liu M, He J, Wu S, Chen M, Wan Y, et al. Comparison of Different Risk-Stratification Systems for the Diagnosis of Benign and Malignant Thyroid Nodules. Front Oncol. 2018 May 14;9:378.

Park J-Y, Lee HJ, Jang HW, Kim HK, Yi JH, Lee W, et al. A Proposal for a Thyroid Imaging Reporting and Data System for Ultrasound Features of Thyroid Carcinoma. Thyroid. 2009 Nov;19(11):1257–64.

Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 2009 May;94(5):1748–51.

Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011 Sep;260(3):892–9.

Grani G, Lamartina L, Ascoli V, Bosco D, Biffoni M, Giacomelli L, et al. Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: towards the “right” TIRADS. J Clin Endocrinol Metab [Internet]. 2018 Oct 8;

Zayadeen AR, Abu-Yousef M, Berbaum K. JOURNAL CLUB: Retrospective Evaluation of Ultrasound Features of Thyroid Nodules to Assess Malignancy Risk: A Step Toward TIRADS. Am J Roentgenol. 2016 Sep;207(3):460–9.

Yoon SJ, Na DG, Gwon HY, Paik W, Kim WJ, Song JS, et al. Similarities and Differences Between Thyroid Imaging Reporting and Data Systems. Am J Roentgenol. 2018 Mar 27;1–9.

Li Q, Lin X, Shao Y, Xiang F, Samir AE. Imaging and Screening of Thyroid Cancer. Radiol Clin North Am. 2017 Nov;55(6):1261–71.


  • There are currently no refbacks.